Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Breast (Edinburgh, Scotland)|February 26, 2022
Obstetric complications at time of delivery amongst breast cancer survivors: A population-based cohort studyOrit Kaidar-Person, Rakefet Yoeli-Ullman, Nir Pillar, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Estimating normal tissue toxicity in radiosurgery of the CNS: application and limitations of QUANTECJohn P Kirkpatrick, Lawrence B Marks, Charles S Mayo, et al.
Harefuah|February 23, 2022
[DELAY IN DIAGNOSIS AND TREATMENT IN BREAST CANCER PATIENTS DURING THE COVID-19 PANDEMIC - CASE STUDY]Inbal Greenhouse, Amit Itay, Miri Sklair Levy, et al.
The Israel Medical Association Journal : IMAJ|March 12, 2016
Impact of Androgen Deprivation Therapy on Sexual and Hormonal Function in Patients Receiving Radiation Therapy for Prostate CancerTamara Kushnir, Ofer N Gofrit, Ruth Elkayam, et al.
Cancer Reports (Hoboken, N.J.)|June 2, 2022
Serological response to a third booster dose of BNT162b2 COVID-19 vaccine among seronegative cancer patientsEinat Shacham Shmueli, Yaacov R Lawrence, Galia Rahav, et al.
Journal of Oncology Practice|January 3, 2012
Patient-oriented cancer information on the internet: a comparison of wikipedia and a professionally maintained databaseMalolan S Rajagopalan, Vineet K Khanna, Yaacov Leiter, et al.
Cancers|July 2, 2021
Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung CancerAmir Onn, Teodor Gottfried, Amos Stemmer, et al.
American Journal of Clinical Oncology|July 1, 2015
Do Prostate Cancer Patients With Markedly Elevated PSA Benefit From Radiation Therapy?: A Population-based StudyYaacov R Lawrence, Benzion Samueli, Ronald Levitin, et al.
American Journal of Clinical Oncology|September 23, 2016
A Retrospective Feasibility Study of Salvage Pelvic Nodal Radiation in 6 Patients With Biochemical Failure Following Prostate Fossa Radiation: An Alternative to Androgen Deprivation Therapy (ADT)Zvi Symon, Guy Ben-Bezalel, Ben Spieler, et al.
Endocrine-Related Cancer|September 10, 2011
mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancerMatthew J Schiewer, Robert Den, David T Hoang, et al.
Pageof 6